Genzyme earnings plummet on plant closure
Genzyme's fourth-quarter earnings dropped 73 percent because of manufacturing problems that the maker of rare-disease treatments expects will continue to hurt earnings this year. Report
Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product
Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.
